A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - Taylor & Francis
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …
被引用次数：18 相关文章

A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - dovepress.com
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …
[PDF] scienceopen.com

[PDF][PDF] A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - scienceopen.com
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …

A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - search.proquest.com
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan
Page 1 © 2015 Tanimoto. This work is published by Dove Medical Press Limited, and licensed …

[引用][C] A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - cir.nii.ac.jp
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug design, development and therapy, 2015 - pubmed.ncbi.nlm.nih.gov
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …
[PDF] core.ac.uk

[PDF][PDF] A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - core.ac.uk
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …

A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - go.gale.com
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …
[PDF] psu.edu

[PDF][PDF] A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - Citeseer
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …
[PDF] semanticscholar.org

[PDF][PDF] A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan

T Tanimoto - Drug Design, Development and Therapy, 2015 - pdfs.semanticscholar.org
The universal health care system in Japan is facing a historical turning point as a result of
the increasing fiscal burden, rapidly aging society, and a decreasing population. To …